Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312471 (2-[5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-3,4-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234674 (US9353102, 3.3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234681 (US9353102, 4.5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234682 (US9353102, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234684 (US9353102, 6.1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312313 (2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-4,5...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312314 (3-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-4,5...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312340 (2-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,5,6,7-tetr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312342 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-methy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312344 (2-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,7-dihydro-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312347 (3-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-methy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312350 (2-[3-(4-Cyclopropyl-thiazol-2-yl)-4,7-dihydro-5H-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312356 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,4-dim...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312380 (2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-5,6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312382 (3-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-5,6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312389 (2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-5,6...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312401 (2-[6,6-Difluoro-3-(3-trifluoromethyl-[1,2,4]oxadia...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312447 (2-[6-Ethyl-3-(4-methyl-thiazol-2-yl)-4,5,6,7-tetra...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312453 (2-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-6,6-di...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312490 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-5,5-dim...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234701 (US9353102, 4.7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312493 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312510 ((R)-1-[[3-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312465 (3-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-4,5,6,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234707 (US9353102, 4.13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234709 (US9353102, 4.15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312420 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-ethyl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312421 (2-[(S)-3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312472 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234692 (US9353102, 6.9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM234709 (US9353102, 4.15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312460 (2-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-4,5,6,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312500 (4-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312422 (2-[(R)-3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-e...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312454 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-fluor...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312473 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6,7-dih...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234711 (US9353102, 4.17) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312472 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234691 (US9353102, 6.8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19.2 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234673 (US9353102, 3.2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234678 (US9353102, 4.2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234679 (US9353102, 4.3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234683 (US9353102, 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM234687 (US9353102, 6.4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp... | US Patent US9353102 (2016) BindingDB Entry DOI: 10.7270/Q23F4NH4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312313 (2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-4,5...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312319 (2-[3-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312320 (3-[3-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein 5 (Homo sapiens (Human)) | BDBM312330 (2-[4,4-Dimethyl-3-(3-methyl-[1,2,4]oxadiazol-5-yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312331 (2-[3-(4-Methyl-oxazol-2-yl)-4,7-dihydro-5H-thieno[...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fatty acid-binding protein, adipocyte (Homo sapiens (Human)) | BDBM312338 (2-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,5,6,7-tetr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra... | US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 713 total ) | Next | Last >> |